简介：
Overview
This protocol outlines procedures for generating spontaneous metastatic renal cell carcinoma (RCC) in a clinically relevant model. It includes steps for orthotopic kidney tumor cell implantation, nephrectomy, and necropsy for assessing metastatic burden.
Key Study Components
Area of Science
- Oncology
- Neuroscience
- Pathology
Background
- Spontaneous metastatic RCC models are essential for evaluating new treatments.
- Orthotopic implantation mimics natural disease progression.
- Nephrectomy allows for the study of metastasis post-tumor removal.
- Standardized assessment methods are crucial for therapeutic efficacy evaluation.
Purpose of Study
- To create a model of spontaneous metastatic RCC.
- To assess disease progression and therapeutic responses.
- To provide a guideline for evaluating experimental treatments.
Methods Used
- Preparation of renal tumor cells for implantation.
- Orthotopic implantation of kidney tumor cells.
- Nephrectomy to remove the primary tumor.
- Monitoring of metastasis and disease distribution post-surgery.
Main Results
- Successful establishment of spontaneous metastatic RCC model.
- Effective monitoring of tumor growth and metastasis.
- Guidelines for necropsy and scoring of metastatic burden.
- Standardized methods for evaluating treatment efficacy.
Conclusions
- This protocol provides a reliable model for RCC research.
- It facilitates the assessment of new therapeutic strategies.
- Standardization enhances reproducibility and comparability of results.
What is the significance of using an orthotopic model?
Orthotopic models closely mimic the natural environment of tumors, providing more clinically relevant data.
How does nephrectomy impact the study?
Nephrectomy allows researchers to study the progression of metastasis after the primary tumor is removed.
What are the key steps in this protocol?
The key steps include cell preparation, implantation, nephrectomy, and necropsy for assessment.
What outcomes can be measured in this study?
Outcomes include tumor growth, metastasis localization, and treatment efficacy.
How can this model be used in therapeutic research?
It can be used to evaluate the effectiveness of new drugs and treatment strategies in a controlled setting.
What is the role of bioluminescent scoring?
Bioluminescent scoring allows for sensitive detection and quantification of metastatic burden.
繁體中文
